相似文献
1
Draft Genomes of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain MM66 and MM66 Derivatives with Altered Vancomycin Resistance Levels.
Genome Announc. 2014 Jul 10;2(4):e00688-14. doi: 10.1128/genomeA.00688-14.
2
(Adenine Phosphoribosyltransferase) Mutation in Laboratory-Selected Vancomycin-Intermediate .
Antibiotics (Basel). 2021 May 14;10(5):583. doi: 10.3390/antibiotics10050583.
3
Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus.
Genome Announc. 2014 Oct 9;2(5):e01033-14. doi: 10.1128/genomeA.01033-14.
4
Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
J Microbiol Immunol Infect. 2016 Oct;49(5):701-707. doi: 10.1016/j.jmii.2015.07.003. Epub 2015 Jul 31.
5
Etest Methods for Screening Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) strains.
Curr Microbiol. 2020 Oct;77(10):3158-3167. doi: 10.1007/s00284-020-02123-y. Epub 2020 Jul 30.
6
Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.
J Clin Microbiol. 2011 Dec;49(12):4203-7. doi: 10.1128/JCM.01152-11. Epub 2011 Oct 5.
7
Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.
PLoS One. 2013 Sep 12;8(9):e73300. doi: 10.1371/journal.pone.0073300. eCollection 2013.
8
Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
Antimicrob Agents Chemother. 2013 Dec;57(12):5843-53. doi: 10.1128/AAC.00425-13. Epub 2013 Sep 9.
9
Protein Biomarker Discovery for Methicillin-Sensitive, Heterogeneous Vancomycin-Intermediate and Vancomycin-Intermediate Strains Using Label-Free Data-Independent Acquisition Proteomics.
J Proteome Res. 2021 Jan 1;20(1):164-171. doi: 10.1021/acs.jproteome.0c00134. Epub 2020 Oct 15.
10
[The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
Zhonghua Nei Ke Za Zhi. 2013 Apr;52(4):318-22.
引用本文的文献
1
(Adenine Phosphoribosyltransferase) Mutation in Laboratory-Selected Vancomycin-Intermediate .
Antibiotics (Basel). 2021 May 14;10(5):583. doi: 10.3390/antibiotics10050583.
2
Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus.
Genome Announc. 2014 Oct 9;2(5):e01033-14. doi: 10.1128/genomeA.01033-14.
本文引用的文献
1
Proof of Principle for a Real-Time Pathogen Isolation Media Diagnostic: The Use of Laser-Induced Breakdown Spectroscopy to Discriminate Bacterial Pathogens and Antimicrobial-Resistant Staphylococcus aureus Strains Grown on Blood Agar.
J Pathog. 2013;2013:898106. doi: 10.1155/2013/898106. Epub 2013 Sep 10.
2
Isolation and characterization of Staphylococcus aureus strains from a Paso del Norte dairy.
J Dairy Sci. 2013 Jun;96(6):3535-42. doi: 10.3168/jds.2013-6590. Epub 2013 Apr 19.
3
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.
Clin Infect Dis. 2011 Feb 1;52(3):285-92. doi: 10.1093/cid/cir034.
4
ABySS: a parallel assembler for short read sequence data.
Genome Res. 2009 Jun;19(6):1117-23. doi: 10.1101/gr.089532.108. Epub 2009 Feb 27.
5
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Antimicrob Agents Chemother. 2009 Mar;53(3):1231-4. doi: 10.1128/AAC.01173-08. Epub 2009 Jan 5.
6
Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus.
Antimicrob Agents Chemother. 2008 Oct;52(10):3755-62. doi: 10.1128/AAC.01613-07. Epub 2008 Jul 21.
7
The RAST Server: rapid annotations using subsystems technology.
BMC Genomics. 2008 Feb 8;9:75. doi: 10.1186/1471-2164-9-75.
8
Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 2008 Apr;52(4):1221-9. doi: 10.1128/AAC.01164-07. Epub 2008 Jan 22.
9
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
Antimicrob Agents Chemother. 2008 Jan;52(1):45-53. doi: 10.1128/AAC.00534-07. Epub 2007 Oct 22.
10
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 2007 Aug;51(8):2679-89. doi: 10.1128/AAC.00209-07. Epub 2007 May 14.
Zotero 插件